Literature DB >> 9510074

Free radicals in retinal ischemia.

C Bonne1, A Muller, M Villain.   

Abstract

1. Reactive oxygen species (ROS) can be generated in biological tissues, including the retina, in particular under or after ischemia. They can provoke cell necrosis by reacting with cell components or they can trigger programmed cell death by activating specific targets. 2. Experiments based on electroretinography and electron spin resonance spin trapping analysis show that ROS are produced in the rabbit retina during ischemic episodes themselves as well as reperfusion. ROS are also generated as a consequence of ischemia by overstimulation of glutamate ionotropic receptors and calcium-dependent activation of enzymes such as phospholipase A2 and nitric oxide synthase. 3. The targets of ROS that can be responsible for functional damage of the retina are numerous: Na+-K+-ATPase inhibition leads to ionic imbalance and electroretinogram alteration; inhibition of glutamate transporter contributes to excitotoxicity. In addition, ROS can be deleterious by inducing protein synthesis (e.g., apoptotic proteins, vascular endothelial growth factor/vascular permeability factor). 4. In this short review, we consider the various mechanisms of ROS generation in retinal ischemia and the different effects of ROS so as to suggest possible effects of neuroprotective agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510074     DOI: 10.1016/s0306-3623(97)00357-1

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  29 in total

1.  Neuroglobin protection in retinal ischemia.

Authors:  Anita S Y Chan; Sindhu Saraswathy; Matus Rehak; Mari Ueki; Narsing A Rao
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

2.  [Neurodegeneration and neuroprotection].

Authors:  K-G Schmidt
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

3.  Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis.

Authors:  Nigar Fatma; E Kubo; M Sen; N Agarwal; W B Thoreson; C B Camras; D P Singh
Journal:  Brain Res       Date:  2008-07-29       Impact factor: 3.252

4.  D-allose as ischemic retina injury inhibitor during rabbit vitrectomy.

Authors:  Masanori Mizote; Kazuyuki Hirooka; Kouki Fukuda; Takehiro Nakamura; Toshifumi Itano; Fumio Shiraga
Journal:  Jpn J Ophthalmol       Date:  2011-05-13       Impact factor: 2.447

5.  Acute retinal ischemia inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production.

Authors:  Travis W Hein; Yi Ren; Luke B Potts; Zhaoxu Yuan; Enoch Kuo; Robert H Rosa; Lih Kuo
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-03       Impact factor: 4.799

Review 6.  Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2006-09-07       Impact factor: 21.198

7.  Involvement of ER stress in retinal cell death.

Authors:  Masamitsu Shimazawa; Yuta Inokuchi; Yasushi Ito; Hiroshi Murata; Makoto Aihara; Masayuki Miura; Makoto Araie; Hideaki Hara
Journal:  Mol Vis       Date:  2007-04-05       Impact factor: 2.367

8.  A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure.

Authors:  Matthew J Hartsock; Hongkwan Cho; Lijuan Wu; Wan-Ju Chen; Junsong Gong; Elia J Duh
Journal:  J Vis Exp       Date:  2016-07-14       Impact factor: 1.355

9.  Metipranolol attenuates lipid peroxidation in rat brain: a comparative study with other antiglaucoma drugs.

Authors:  José Melena; Neville N Osborne
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-07-29       Impact factor: 3.117

10.  Comparison of bee products based on assays of antioxidant capacities.

Authors:  Yoshimi Nakajima; Kazuhiro Tsuruma; Masamitsu Shimazawa; Satoshi Mishima; Hideaki Hara
Journal:  BMC Complement Altern Med       Date:  2009-02-26       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.